Recently, a prospective study presented that CEA ≥ 40 ng/mL was a risk factor for brain metastasis development and was associated with poor prognosis in patients with advanced NSCLC [15]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.